Sanofi (SNY) stock

Medicines and vaccines , market cap $112B

Medicines and vaccines

Worth $112B

$48.23

+0.23%

FDA in 15 daysEvery upcoming FDA date ›

As of Tuesday's close · Live for Pro members at the open

Quality Score

Average

In its industry

#30of 90

Pharma

Checks firing

4of 14

Trending down

From 52-week high

-8.4%

under its best in a year

SNY's Quality Score was unchanged on Tue, Nov 10, at 7.

Follow SNY's trial news. Pro members can get an alert when Sanofi files news, and see its trials, share raises, and its CEO's filings.

Get an alert when SNY files news on its trialsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

NextNov 25, 2026 · In 15 days“The target action date for the FDA decision is November 25, 2026.”FDA decision date · SEC filing · Jul 30

Why is SNY up?

Up 15% from Oct 27 to Nov 10.

“Pharma launches sales increased by 31.4%, reaching €1.4 billion, driven by ALTUVIIIO, Ayvakit, and Rezurock.”

Sanofi's Oct 30 release said

Sources: Price history, Nov 10, 2026; Company release, Oct 30, 2026

1 more reason, free with an account →2 more reasons why SNY rose 15% since Oct 27, from its filings, with the company's words, the timeline, and its peers, for Pro members.

Why SNY still lags the market over three years

Up 22% over the three years to Nov 9 while the S&P 500 rose 80%; up 15% since Oct 27.

1 reason, from its filings, with the timeline and its peers, for Pro members.

Key facts on SNY

Key facts on SNY
The company	Profit up 40% to €7.9B
Latest filing	6-K, Oct 1 Issued a release: "Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies"

1 more reason behind SNY's 7, free with an account →

SNY in the news

Fri Oct 30Sanofi Raises Profit Forecast on Blockbuster Dupixent Sales Bloomberg and 3 more SNY closed +2.8% that day.

Big story

Guidance

Sanofi Raises Profit Forecast on Blockbuster Dupixent Sales

SNY closed +2.8% that day on 5.2x normal volume.

Reported by Bloomberg · covered by 5 outlets

Get an alert on SNY's next big story →

Outlet counts from the GDELT Project. The move is what SNY did that session, not a claim about why.

What's next

Reports Thu Jan 28, before the open

After its last 4 reports it closed +0.2% on average, higher 3 of 4 times.

Wed Apr 28: Annual Shareholder MeetingDate confirmed.

SNY catalysts

Coming up

4 more coming up and 53 past catalysts since 2020, with sizes and sources, for Pro members.

What's next for SNY

Next step the company has named

Nov 25In 15 days“The target action date for the FDA decision is November 25, 2026.”FDA decision date · SEC filing · Jul 30

What it means: the date by which the FDA has said it aims to decide on the company’s application. The FDA can decide earlier, or extend the date.

Dilution on the horizon

Shelf registration (F-3ASR, filed Apr 4, 2024)

For Pro members: the amounts, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From Form 4: open-market buys and sales only.

For Pro members: every trade.

Get an alert before SNY's FDA date

A free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

Why SNY scores 7

Averagefor quality, not price, 4 of 14 chart checks firingWhat the Quality Score means

+4Chart checks 4 of 14 firing right now, one point each
+2Profit A profit of €7.9B in the year to Dec 31, 2025, up 40% from €5.6B the year before, from the SEC filingRead on the last four quarters against the four before, or the last full year where no quarters are filed.

Size adds

No effect today: Long-term trend, Run-up, Growth, Dilution, Volatility, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on SNY and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 10:56 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when SNY's Quality Score turns up

A free account. No card.

How SNY ranks in Pharma

SNY is #30 of 90 by Quality Score.

How SNY ranks in Pharma
Rank	Stock	Checks	Quality Score
1	ABBVAbbVie	10/14	23
2	LLYEli Lilly	8/14	21
3	PFEPfizer	6/14	17
	SIGASIGA Technologies		Open for its score
	SLSSELLAS Life Sciences		Open for its score
	SUPNSupernus		Open for its score
	SVRASavara		Open for its score
30	SNYSanofi	4/14	7

When does SNY report earnings, and what happens after?

Reports Thu Jan 28, before the open (in 79 days). Confirmed.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

Close after the report, last 3

+1.3%-4.4%+2.8%

Apr 23Jul 30Oct 30

Reported	When	Gap	Reaction	5 days
Oct 30, 2026Before open	Before open	+3.9%	+2.8%	+8.8%
Jul 30, 2026Before open	Before open	-6.3%	-4.4%	-4.6%
Apr 23, 2026Before open	Before open	+3.4%	+1.3%	-1.9%

SNY closed higher after 3 of its last 4 reports.

All 4 reports, and SNY's Quality Score going into each

SNY has 4 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on SNY, and all 14 on every stock.Get in free →

SNY RSI today: 76.5, above its 50-day and 200-day averages

Not scored

RSI 76.5, MACD above signal, above both averages. Not scored.13 readings

The deep dive on SNY

What it does and how it makes money1 findingFor Pro members1 finding on what SNY does and how it makes money, for Pro members
Where it stands2 findingsPaid $2.42 a share in dividends over the last year, in 1 payment.Ex-dividend dates and amounts, from the market data vendor
Who holds and trades it1 findingFor Pro members1 finding on who holds and trades SNY, for Pro members
Against its closest peers4 peersFor Pro membersSNY against 4 peers, fact by fact, for Pro members

3 more findings on SNY, each with its source, for Pro members.

SNY share count over time

Shares of SNY outstanding, as filed
Shares outstanding	As of
1.22B	Dec 31, 2025
1.26B	Dec 31, 2024
1.26B	Dec 31, 2023
1.26B	Dec 31, 2022

Offerings, shelves, and splits of SNY, from its filings
From its filings	Filed
Registered shares for a later sale (F-3ASR)	Apr 4, 2024

SNY insider trades

SNY trades by Congress and the executive branch

One trade disclosed in the last six months. The newest:

BuyAlan Armstrong$15K to $50KSenatetraded Mar 30, disclosed Jul 21(113 days later)

BuyAlan ArmstrongSenate$15K to $50Ktraded Mar 30, disclosed Jul 21(113 days later)

See what Congress is buying across the market

About Sanofi

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

74,846 employeessanofi.com

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on SNY and every other stock.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would move SNY's score: 4 things
4 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawayJul 21Alan Armstrong bought SNY$15K to $50K, disclosed Jul 21

Alerts are optional.

See SNY's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: SNY's Quality Score is 7 (Average), #30 of 90 in Pharma.

What does SNY's Quality Score say?

SNY scores 7 today, which Breakaway calls Average. It is #30 of 90 in Pharma by Quality Score, with 4 of 14 chart checks firing. Up 15% from Oct 27 to Nov 10. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is SNY's Quality Score?

SNY scores 7 today, which Breakaway calls Average (6 to 10). That is #30 of 90 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind SNY's 7.

When does SNY report earnings?

Reports Thu Jan 28, before the open, a date the company confirmed. SNY closed higher after 3 of its last 4 reports. Past behavior, not a forecast.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.